"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","25/40","481/2914",5.52638454719541e-11,2.5310841226155e-08,1.72772232686004e-08,"E2F6/CTNNB1/FOXO1/EP300/ESR1/MAPK1/ABL1/E2F1/BRCA1/PPP2R5C/MAPK3/PRKAA1/YAP1/SMAD3/STK11/NR2C2/KLF4/SMAD4/TWIST1/TP53/CSNK2A1/NR2C2AP/NOTCH1/STAT1/GATA2",25
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","25/40","499/2914",1.27457565435433e-10,2.91877824847142e-08,1.99236299654335e-08,"E2F6/CTNNB1/FOXO1/EP300/ESR1/MAPK1/ABL1/E2F1/BRCA1/PPP2R5C/MAPK3/PRKAA1/YAP1/SMAD3/STK11/NR2C2/KLF4/SMAD4/TWIST1/TP53/CSNK2A1/NR2C2AP/NOTCH1/STAT1/GATA2",25
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","6/40","27/2914",1.08679356104792e-06,0.000109367132276958,7.46541904993255e-05,"EP300/E2F1/STAT3/CEBPB/CEBPA/GATA2",6
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","18/40","397/2914",1.15274774435702e-06,0.000109367132276958,7.46541904993255e-05,"CTNNB1/FOXO1/EP300/MAPK1/ABL1/E2F1/MAPK3/ROCK2/SMAD3/KDM6A/STAT3/CEBPB/KLF4/SMAD4/CSNK2A1/NOTCH1/CEBPA/GATA2",18
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","8/40","62/2914",1.19396432616766e-06,0.000109367132276958,7.46541904993255e-05,"ESR1/MAPK1/ABL1/MAPK3/YAP1/SMAD4/TWIST1/STAT1",8
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","7/40","53/2914",5.15853265850236e-06,0.000375363912676246,0.00025622404519615,"CTNNB1/EP300/YAP1/SMAD3/SMAD4/TP53/NOTCH1",7
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","14/40","268/2914",5.73700303216969e-06,0.000375363912676246,0.00025622404519615,"CTNNB1/FOXO1/EP300/ESR1/MAPK1/PPP2R5C/MAPK3/SMAD3/STAT3/SMAD4/NOTCH1/STAT1/GSK3A/AMER1",14
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","5/40","24/2914",1.32353296875264e-05,0.000757722624610889,0.000517222752262546,"MAPK1/ABL1/MAPK3/YAP1/SMAD4",5
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","4/40","14/2914",2.76255415742898e-05,0.00140583311566942,0.000959624075738489,"FOXO1/SMAD3/KLF4/SMAD4",4
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","6/40","49/2914",4.11137388999605e-05,0.00188300924161819,0.00128534531087245,"FOXO1/EP300/SMAD3/STK11/KLF4/SMAD4",6
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/40","19/2914",0.000101788472578843,0.00423810185828274,0.00289293553645133,"MAPK1/ABL1/MAPK3/YAP1",4
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","10/40","191/2914",0.000173384942192691,0.00661752529368769,0.00451713402028326,"E2F6/EP300/MAPK1/ABL1/E2F1/PPP2R5C/MAPK3/PLK1/TP53/CSNK2A1",10
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","4/40","23/2914",0.000223493837490047,0.00715410922853839,0.004883407126812,"EP300/E2F1/TP53/NOTCH1",4
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/40","23/2914",0.000223493837490047,0.00715410922853839,0.004883407126812,"MAPK1/E2F1/MAPK3/TP53",4
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","7/40","95/2914",0.00024224921165806,0.00715410922853839,0.004883407126812,"EP300/BRCA1/PPP2R5C/PRKAA1/STK11/TP53/CSNK2A1",7
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","10/40","201/2914",0.000264955373049612,0.00715410922853839,0.004883407126812,"FOXO1/ESR1/MAPK1/PPP2R5C/MAPK3/TP53/CSNK2A1/GSK3A/PRKCD/KPNA2",10
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/40","24/2914",0.000265545539050551,0.00715410922853839,0.004883407126812,"MAPK1/MAPK3/STAT3/STAT1",4
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","8/40","130/2914",0.000290816855427704,0.00739967332143825,0.00505102959427065,"CTNNB1/MAPK1/ABL1/PPP2R5C/MAPK3/ROCK2/PLK1/PRKCD",8
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","11/40","249/2914",0.000350170764729279,0.00799431388731386,0.00545693225587731,"E2F6/EP300/MAPK1/ABL1/E2F1/BRCA1/PPP2R5C/MAPK3/PLK1/TP53/CSNK2A1",11
"R-HSA-109581","R-HSA-109581","Apoptosis","7/40","101/2914",0.000354894753118605,0.00799431388731386,0.00545693225587731,"CTNNB1/MAPK1/E2F1/MAPK3/STAT3/TP53/PRKCD",7
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","3/40","11/2914",0.000366551510117011,0.00799431388731386,0.00545693225587731,"STAT3/KLF4/SMAD4",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","7/40","103/2914",0.000400651205455545,0.00834082964084725,0.00569346449857879,"CTNNB1/MAPK1/E2F1/MAPK3/STAT3/TP53/PRKCD",7
"R-HSA-1643685","R-HSA-1643685","Disease","15/40","443/2914",0.000432389573231892,0.00861019237131333,0.00587733195651588,"CTNNB1/FOXO1/EP300/ESR1/MAPK1/PPP2R5C/MAPK3/SMAD3/STAT3/SMAD4/NOTCH1/STAT1/GSK3A/AMER1/KPNA2",15
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","5/40","49/2914",0.000461585257348085,0.00880858532772595,0.00601275532598163,"MAPK1/E2F1/MAPK3/STAT3/TP53",5
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","4/40","29/2914",0.000564836161386998,0.0103477984766098,0.00706342483923952,"EP300/E2F1/TP53/NOTCH1",4
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","3/40","13/2914",0.000623338535351598,0.0109803480458089,0.00749520425098885,"FOXO1/EP300/STK11",3
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","3/40","14/2914",0.000785805715472681,0.0112468443027028,0.00767711504919034,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","3/40","14/2914",0.000785805715472681,0.0112468443027028,0.00767711504919034,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","3/40","14/2914",0.000785805715472681,0.0112468443027028,0.00767711504919034,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","3/40","14/2914",0.000785805715472681,0.0112468443027028,0.00767711504919034,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","3/40","14/2914",0.000785805715472681,0.0112468443027028,0.00767711504919034,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","3/40","14/2914",0.000785805715472681,0.0112468443027028,0.00767711504919034,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/40","56/2914",0.00086170542657767,0.0119594268294719,0.00816352509389372,"BRCA1/PRKAA1/STK11/TP53/CSNK2A1",5
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","6/40","86/2914",0.000950712300771993,0.0128066539339286,0.00874184375632452,"EP300/ESR1/ABL1/YAP1/CSNK2A1/GATA2",6
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","4/40","34/2914",0.00104959819217689,0.013734742057629,0.0093753582880161,"MAPK1/PPP2R5C/MAPK3/DUSP2",4
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","4/40","35/2914",0.0011733551068091,0.0142955314260107,0.00975815406464069,"ABL1/BRCA1/TP53/KPNA2",4
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","3/40","16/2914",0.00118609212704892,0.0142955314260107,0.00975815406464069,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/40","16/2914",0.00118609212704892,0.0142955314260107,0.00975815406464069,"MAPK1/MAPK3/PRKCD",3
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/40","17/2914",0.00142659292789606,0.0167533220763178,0.0114358461426486,"EP300/SMAD3/NOTCH1",3
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","3/40","18/2914",0.0016956793146683,0.0189419786858069,0.012929826866662,"E2F6/E2F1/BRCA1",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/40","18/2914",0.0016956793146683,0.0189419786858069,0.012929826866662,"EP300/NOTCH1/STAT1",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","6/40","97/2914",0.00178756565000122,0.0194929778023943,0.013305939800761,"MAPK3/PIAS1/CIITA/STAT1/PRKCD/KPNA2",6
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","8/40","172/2914",0.00188905548826721,0.0198586196126634,0.013555527522319,"FOXO1/ESR1/MAPK1/PPP2R5C/MAPK3/TP53/CSNK2A1/GSK3A",8
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","4/40","40/2914",0.00194912681094063,0.0198586196126634,0.013555527522319,"EP300/CEBPB/KLF4/CEBPA",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","6/40","99/2914",0.00198634422066675,0.0198586196126634,0.013555527522319,"MAPK1/E2F1/MAPK3/STAT3/CEBPB/TP53",6
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/40","19/2914",0.00199453384756007,0.0198586196126634,0.013555527522319,"FOXO1/SMAD3/SMAD4",3
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","3/40","20/2914",0.0023242788205376,0.022649355315026,0.0154604884591191,"MAPK1/MAPK3/CSNK2A1",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/40","104/2914",0.00255698991471473,0.0243979454362363,0.0166540790497867,"EP300/E2F1/SMAD3/TP53/NOTCH1/STAT1",6
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","4/40","44/2914",0.00278296507067682,0.0260122041299997,0.0177559747796137,"MAPK1/E2F1/MAPK3/TP53",4
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/40","45/2914",0.00302443489222621,0.0277038236127921,0.0189106771156039,"MAPK1/MAPK3/STAT3/CEBPB",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/40","23/2914",0.00350920922158241,0.030675375981286,0.0209390638162306,"MAPK1/MAPK3/DUSP2",3
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","4/40","47/2914",0.00354977058298724,0.030675375981286,0.0209390638162306,"MAPK1/MAPK3/PRKAA1/KPNA2",4
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","4/40","47/2914",0.00354977058298724,0.030675375981286,0.0209390638162306,"PIAS1/CIITA/STAT1/PRKCD",4
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/40","24/2914",0.0039725897476584,0.0336157347197466,0.0229461576919438,"FOXO1/EP300/NOTCH1",3
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","8/40","194/2914",0.00403682403839752,0.0336157347197466,0.0229461576919438,"EP300/E2F1/BRCA1/PPP2R5C/PRKAA1/STK11/TP53/CSNK2A1",8
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","4/40","49/2914",0.00413422228576842,0.0338120322657489,0.0230801507306997,"MAPK1/MAPK3/PRKAA1/KPNA2",4
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/40","25/2914",0.00447162389961615,0.0359298902811263,0.0245258042139612,"MAPK1/ABL1/MAPK3",3
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/40","26/2914",0.00500710533646942,0.0388687160017457,0.0265318516490886,"MAPK1/PRKCD/KPNA2",3
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","3/40","26/2914",0.00500710533646942,0.0388687160017457,0.0265318516490886,"ESR1/TWIST1/STAT1",3
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","3/40","27/2914",0.00557977813465998,0.0425923064279045,0.0290735808069125,"ABL1/YAP1/GATA2",3
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","6/40","124/2914",0.00614456042172493,0.0461345684122954,0.0314915348619897,"EP300/ESR1/BRCA1/SMAD3/SMAD4/TP53",6
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/40","30/2914",0.00752767090424333,0.0497561424302799,0.0339636274460886,"STAT3/TP53/CSNK2A1",3
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","3/40","30/2914",0.00752767090424333,0.0497561424302799,0.0339636274460886,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","3/40","30/2914",0.00752767090424333,0.0497561424302799,0.0339636274460886,"EP300/E2F1/TP53",3
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"MAPK1/MAPK3",2
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"MAPK1/MAPK3",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"MAPK1/MAPK3",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"STAT3/STAT1",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"STAT3/STAT1",2
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"FOXO1/EP300",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/40","10/2914",0.00771328845534907,0.0497561424302799,0.0339636274460886,"MAPK1/MAPK3",2
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","4/40","59/2914",0.00804641123473665,0.0510955112382293,0.0348778828723376,"MAPK1/MAPK3/TP53/CSNK2A1",4
"R-HSA-391251","R-HSA-391251","Protein folding","3/40","31/2914",0.00825560661927722,0.0510955112382293,0.0348778828723376,"STAT3/TP53/CSNK2A1",3
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","3/40","31/2914",0.00825560661927722,0.0510955112382293,0.0348778828723376,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/40","94/2914",0.00844970281153306,0.0515995185024286,0.0352219190880747,"FOXO1/STAT3/TWIST1/TP53/STAT1",5
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/40","32/2914",0.00902375828593886,0.0541825401614366,0.0369850940656095,"MAPK1/MAPK3/TP53",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/40","11/2914",0.00934589666540064,0.0541825401614366,0.0369850940656095,"STAT3/STAT1",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/40","11/2914",0.00934589666540064,0.0541825401614366,0.0369850940656095,"E2F1/TP53",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/40","11/2914",0.00934589666540064,0.0541825401614366,0.0369850940656095,"STAT3/STAT1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","4/40","62/2914",0.00957522653861027,0.0548181719335438,0.0374189773943059,"MAPK1/ABL1/MAPK3/PRKCD",4
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/40","33/2914",0.00983260084588424,0.0553495884298293,0.0377817231984815,"MAPK1/MAPK3/PLK1",3
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","8/40","228/2914",0.010637531462725,0.0553495884298293,0.0377817231984815,"CTNNB1/MAPK1/ABL1/PPP2R5C/MAPK3/ROCK2/PLK1/PRKCD",8
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/40","34/2914",0.0106825688446301,0.0553495884298293,0.0377817231984815,"MAPK1/PRKCD/KPNA2",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/40","34/2914",0.0106825688446301,0.0553495884298293,0.0377817231984815,"MAPK1/PRKCD/KPNA2",3
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","3/40","34/2914",0.0106825688446301,0.0553495884298293,0.0377817231984815,"MAPK3/STAT1/KPNA2",3
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/40","34/2914",0.0106825688446301,0.0553495884298293,0.0377817231984815,"ABL1/BRCA1/TP53",3
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/40","12/2914",0.0111182579378696,0.0553495884298293,0.0377817231984815,"MAPK1/MAPK3",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/40","12/2914",0.0111182579378696,0.0553495884298293,0.0377817231984815,"SMAD3/SMAD4",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/40","12/2914",0.0111182579378696,0.0553495884298293,0.0377817231984815,"MAPK1/MAPK3",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/40","12/2914",0.0111182579378696,0.0553495884298293,0.0377817231984815,"STAT3/STAT1",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/40","12/2914",0.0111182579378696,0.0553495884298293,0.0377817231984815,"MAPK1/MAPK3",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/40","12/2914",0.0111182579378696,0.0553495884298293,0.0377817231984815,"EP300/NOTCH1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","3/40","35/2914",0.0115740576325508,0.0566532975319672,0.0386716372488951,"MAPK3/STAT1/KPNA2",3
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","7/40","187/2914",0.0122160478861482,0.0566532975319672,0.0386716372488951,"EP300/MAPK1/E2F1/MAPK3/STAT3/CEBPB/TP53",7
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","7/40","189/2914",0.0129111335599288,0.0566532975319672,0.0386716372488951,"EP300/MAPK1/E2F1/MAPK3/STAT3/CEBPB/TP53",7
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"MAPK1/MAPK3",2
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"PPP2R5C/AMER1",2
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"PPP2R5C/AMER1",2
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"PPP2R5C/AMER1",2
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"PPP2R5C/AMER1",2
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"PPP2R5C/AMER1",2
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"PPP2R5C/AMER1",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"EP300/BRCA1",2
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"EP300/TP53",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/40","13/2914",0.0130264251019638,0.0566532975319672,0.0386716372488951,"EP300/NOTCH1",2
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","4/40","68/2914",0.0131771159656875,0.0566532975319672,0.0386716372488951,"EP300/E2F1/PLK1/TP53",4
"R-HSA-68886","R-HSA-68886","M Phase","5/40","105/2914",0.0133101046685161,0.0566532975319672,0.0386716372488951,"MAPK1/PPP2R5C/MAPK3/PLK1/CSNK2A1",5
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/40","37/2914",0.0134829900239835,0.0566532975319672,0.0386716372488951,"CTNNB1/PPP2R5C/AMER1",3
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/40","37/2914",0.0134829900239835,0.0566532975319672,0.0386716372488951,"EP300/NOTCH1/STAT1",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/40","107/2914",0.0143626666229082,0.059800921029927,0.0408202104019497,"EP300/ESR1/BRCA1/PIAS1/TP53",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","5/40","108/2914",0.0149095664513153,0.0600040867524776,0.0409588916696986,"CTNNB1/EP300/PPP2R5C/CSNK2A1/AMER1",5
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","5/40","108/2914",0.0149095664513153,0.0600040867524776,0.0409588916696986,"EP300/ESR1/MAPK1/MAPK3/KPNA2",5
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/40","14/2914",0.0150665283330457,0.0600040867524776,0.0409588916696986,"MAPK1/MAPK3",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/40","14/2914",0.0150665283330457,0.0600040867524776,0.0409588916696986,"EP300/TP53",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/40","14/2914",0.0150665283330457,0.0600040867524776,0.0409588916696986,"PIAS1/STAT1",2
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/40","109/2914",0.0154704168880434,0.0610814735752058,0.0416943177472676,"EP300/ESR1/BRCA1/PIAS1/TP53",5
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","3/40","40/2914",0.0166655528710521,0.0652357555919538,0.04453003771733,"EP300/SMAD3/NOTCH1",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/40","15/2914",0.0172347738572629,0.0652357555919538,0.04453003771733,"SMAD3/SMAD4",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/40","15/2914",0.0172347738572629,0.0652357555919538,0.04453003771733,"EP300/TP53",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/40","15/2914",0.0172347738572629,0.0652357555919538,0.04453003771733,"E2F6/E2F1",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/40","15/2914",0.0172347738572629,0.0652357555919538,0.04453003771733,"SMAD3/STAT3",2
"R-HSA-73894","R-HSA-73894","DNA Repair","6/40","157/2914",0.01859805861618,0.0698189413623807,0.0476585281191153,"EP300/ABL1/BRCA1/PIAS1/TP53/KPNA2",6
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/40","16/2914",0.0195274426758649,0.071548549964369,0.0488391618924789,"MAPK1/MAPK3",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","2/40","16/2914",0.0195274426758649,0.071548549964369,0.0488391618924789,"PIAS1/TP53",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/40","16/2914",0.0195274426758649,0.071548549964369,0.0488391618924789,"PLK1/TP53",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","4/40","77/2914",0.0200435728485617,0.072856796544772,0.0497321732332735,"MAPK1/MAPK3/PRKAA1/KPNA2",4
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/40","43/2914",0.0202361308579719,0.0729775427791427,0.0498145948182151,"MAPK1/ABL1/MAPK3",3
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","4/40","81/2914",0.0236937448909353,0.0847791809378779,0.0578704130971035,"ABL1/BRCA1/TP53/KPNA2",4
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/40","46/2914",0.0241980436143433,0.0849088301186369,0.0579589118483915,"ESR1/NR2C2/NR2C2AP",3
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","2/40","18/2914",0.0244715405582097,0.0849088301186369,0.0579589118483915,"PRKAA1/STK11",2
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/40","18/2914",0.0244715405582097,0.0849088301186369,0.0579589118483915,"MAPK1/MAPK3",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/40","18/2914",0.0244715405582097,0.0849088301186369,0.0579589118483915,"EP300/CSNK2A1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/40","49/2914",0.0285522955017523,0.097589189103004,0.0666145464573482,"EP300/MAPK1/MAPK3",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/40","49/2914",0.0285522955017523,0.097589189103004,0.0666145464573482,"EP300/ESR1/KPNA2",3
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/40","20/2914",0.0298705182298008,0.101338498883324,0.069173831690065,"SMAD3/SMAD4",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","4/40","88/2914",0.0310081559637597,0.104424525230897,0.0712803585235032,"MAPK1/MAPK3/PRKAA1/KPNA2",4
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","2/40","21/2914",0.0327320487922296,0.108632451788704,0.0741526963485293,"CTNNB1/PRKCD",2
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","2/40","21/2914",0.0327320487922296,0.108632451788704,0.0741526963485293,"MAPK1/MAPK3",2
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/40","53/2914",0.0349661138424841,0.11443390745964,0.0781127798563849,"MAPK1/MAPK3/CSNK2A1",3
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/40","22/2914",0.0356971899064781,0.11443390745964,0.0781127798563849,"CTNNB1/EP300",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/40","22/2914",0.0356971899064781,0.11443390745964,0.0781127798563849,"MAPK1/MAPK3",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/40","22/2914",0.0356971899064781,0.11443390745964,0.0781127798563849,"CTNNB1/ABL1",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/40","92/2914",0.0357293641194946,0.11443390745964,0.0781127798563849,"ESR1/MAPK1/PPP2R5C/MAPK3",4
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/40","136/2914",0.036370174694344,0.115677361180622,0.0789615634811415,"EP300/ESR1/MAPK1/MAPK3/KPNA2",5
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","2/40","23/2914",0.0387627118764682,0.121598096160427,0.0830030672480969,"ABL1/BRCA1",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/40","23/2914",0.0387627118764682,0.121598096160427,0.0830030672480969,"STAT3/STAT1",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/40","56/2914",0.0402283619946368,0.12468737802163,0.0851118163006761,"PPP2R5C/PLK1/CSNK2A1",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","9/40","347/2914",0.0413594550877581,0.12468737802163,0.0851118163006761,"CTNNB1/ESR1/MAPK1/MAPK3/YAP1/ROCK2/STAT3/STAT1/PRKCD",9
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/40","24/2914",0.0419254502518145,0.12468737802163,0.0851118163006761,"STAT3/STAT1",2
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","2/40","24/2914",0.0419254502518145,0.12468737802163,0.0851118163006761,"MAPK1/MAPK3",2
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","2/40","24/2914",0.0419254502518145,0.12468737802163,0.0851118163006761,"SMAD3/SMAD4",2
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","2/40","24/2914",0.0419254502518145,0.12468737802163,0.0851118163006761,"FOXO1/GSK3A",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/40","24/2914",0.0419254502518145,0.12468737802163,0.0851118163006761,"STAT3/STAT1",2
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/40","24/2914",0.0419254502518145,0.12468737802163,0.0851118163006761,"MAPK1/MAPK3",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","4/40","99/2914",0.0449545898694423,0.13014777082068,0.0888390897121169,"ESR1/MAPK1/PPP2R5C/MAPK3",4
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/40","25/2914",0.0451823047172231,0.13014777082068,0.0888390897121169,"PRKCD/KPNA2",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/40","25/2914",0.0451823047172231,0.13014777082068,0.0888390897121169,"PRKCD/KPNA2",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/40","25/2914",0.0451823047172231,0.13014777082068,0.0888390897121169,"MAPK1/MAPK3",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/40","25/2914",0.0451823047172231,0.13014777082068,0.0888390897121169,"EP300/ESR1",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","3/40","59/2914",0.0458723242134599,0.131309528061029,0.0896321071802473,"MAPK1/PRKCD/KPNA2",3
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","2/40","26/2914",0.0485302379989526,0.138054962754784,0.0942365523745597,"CTNNB1/PRKCD",2
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/40","62/2914",0.0518913588439238,0.141669963410404,0.0967041579703289,"ABL1/TP53/GATA2",3
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/40","27/2914",0.0519662747880959,0.141669963410404,0.0967041579703289,"ESR1/YAP1",2
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/40","27/2914",0.0519662747880959,0.141669963410404,0.0967041579703289,"PRKAA1/STK11",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/40","27/2914",0.0519662747880959,0.141669963410404,0.0967041579703289,"EP300/KDM6A",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/40","27/2914",0.0519662747880959,0.141669963410404,0.0967041579703289,"EP300/KDM6A",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/40","27/2914",0.0519662747880959,0.141669963410404,0.0967041579703289,"MAPK1/MAPK3",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/40","27/2914",0.0519662747880959,0.141669963410404,0.0967041579703289,"ESR1/TP53",2
"R-HSA-112316","R-HSA-112316","Neuronal System","4/40","105/2914",0.0538424001154071,0.145427706415598,0.099269199736687,"MAPK1/MAPK3/PRKAA1/KPNA2",4
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","3/40","63/2914",0.0539797163551345,0.145427706415598,0.099269199736687,"ESR1/MAPK1/MAPK3",3
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/40","28/2914",0.055487500680442,0.146897545154002,0.100272514159363,"SMAD3/SMAD4",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/40","28/2914",0.055487500680442,0.146897545154002,0.100272514159363,"ESR1/PIAS1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/40","28/2914",0.055487500680442,0.146897545154002,0.100272514159363,"MAPK1/MAPK3",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"E2F1/TP53",2
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"PPP2R5C/PLK1",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"PPP2R5C/PLK1",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"STAT3/STAT1",2
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"CEBPB/GSK3A",2
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"PPP2R5C/TP53",2
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","2/40","29/2914",0.0590910611326794,0.150353922215373,0.102631843019917,"PPP2R5C/TP53",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/40","66/2914",0.0604863076787628,0.153053750921952,0.104474750686784,"EP300/PLK1/TP53",3
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/40","30/2914",0.0627741604347105,0.155408462049175,0.106082080507021,"PRKCD/KPNA2",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/40","30/2914",0.0627741604347105,0.155408462049175,0.106082080507021,"MAPK1/MAPK3",2
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","2/40","30/2914",0.0627741604347105,0.155408462049175,0.106082080507021,"MAPK1/MAPK3",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/40","30/2914",0.0627741604347105,0.155408462049175,0.106082080507021,"MAPK1/MAPK3",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/40","31/2914",0.0665340606978439,0.163831181718347,0.11183144327821,"STAT3/STAT1",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/40","114/2914",0.0688595971438792,0.166987466493554,0.113985928633844,"BRCA1/PPP2R5C/PLK1/TP53",4
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","3/40","70/2914",0.0697119335270738,0.166987466493554,0.113985928633844,"MAPK1/MAPK3/STAT3",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","2/40","32/2914",0.0703680808586375,0.166987466493554,0.113985928633844,"MAPK1/MAPK3",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/40","32/2914",0.0703680808586375,0.166987466493554,0.113985928633844,"MAPK1/MAPK3",2
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/40","32/2914",0.0703680808586375,0.166987466493554,0.113985928633844,"STAT3/STAT1",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/40","32/2914",0.0703680808586375,0.166987466493554,0.113985928633844,"MAPK1/MAPK3",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/40","32/2914",0.0703680808586375,0.166987466493554,0.113985928633844,"MAPK1/MAPK3",2
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/40","33/2914",0.07427359569817,0.175346942421453,0.119692121119677,"MAPK1/MAPK3",2
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","8/40","332/2914",0.0773353688165882,0.18008844207761,0.122928676849116,"FOXO1/MAPK1/MAPK3/SMAD3/STAT3/TWIST1/TP53/STAT1",8
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/40","34/2914",0.0782480348765163,0.18008844207761,0.122928676849116,"CTNNB1/EP300",2
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/40","34/2914",0.0782480348765163,0.18008844207761,0.122928676849116,"PPP2R5C/PLK1",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/40","34/2914",0.0782480348765163,0.18008844207761,0.122928676849116,"MAPK1/MAPK3",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/40","34/2914",0.0782480348765163,0.18008844207761,0.122928676849116,"BRCA1/TP53",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","2/40","35/2914",0.0822888819822111,0.188441539739263,0.128630515519562,"PRKAA1/TP53",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","5/40","172/2914",0.0834895097161442,0.190239778358179,0.129857996259203,"CTNNB1/EP300/PPP2R5C/CSNK2A1/AMER1",5
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","2/40","36/2914",0.0863936735964845,0.195882685679158,0.133709854393725,"SMAD3/SMAD4",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","3/40","77/2914",0.0872980288080193,0.196958114256516,0.134443943769675,"E2F6/ABL1/E2F1",3
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/40","37/2914",0.0905599983720561,0.202324289045862,0.138106903807449,"EP300/PIAS1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/40","37/2914",0.0905599983720561,0.202324289045862,0.138106903807449,"MAPK1/MAPK3",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/40","38/2914",0.0947854961262788,0.209718633941235,0.143154296209025,"BRCA1/PIAS1",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/40","38/2914",0.0947854961262788,0.209718633941235,0.143154296209025,"MAPK1/MAPK3",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/40","80/2914",0.0953657903309076,0.209988134478633,0.143338257734208,"SMAD3/SMAD4/TP53",3
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/40","40/2914",0.10340482032092,0.2244521692274,0.153211432453546,"EP300/NOTCH1",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","2/40","40/2914",0.10340482032092,0.2244521692274,0.153211432453546,"ABL1/E2F1",2
"R-HSA-69236","R-HSA-69236","G1 Phase","2/40","40/2914",0.10340482032092,0.2244521692274,0.153211432453546,"ABL1/E2F1",2
"R-HSA-109582","R-HSA-109582","Hemostasis","7/40","298/2914",0.107414074238006,0.229626659574254,0.156743548364867,"MAPK1/ABL1/PPP2R5C/MAPK3/TP53/PRKCD/GATA2",7
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/40","41/2914",0.10779417425429,0.229626659574254,0.156743548364867,"STAT3/STAT1",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/40","41/2914",0.10779417425429,0.229626659574254,0.156743548364867,"STAT3/STAT1",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/40","41/2914",0.10779417425429,0.229626659574254,0.156743548364867,"MAPK1/MAPK3",2
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","3/40","85/2914",0.109472668505922,0.231545313205138,0.158053224596474,"CTNNB1/ROCK2/PRKCD",3
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/40","42/2914",0.112233754435678,0.231545313205138,0.158053224596474,"CTNNB1/KLF4",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/40","42/2914",0.112233754435678,0.231545313205138,0.158053224596474,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/40","42/2914",0.112233754435678,0.231545313205138,0.158053224596474,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/40","42/2914",0.112233754435678,0.231545313205138,0.158053224596474,"MAPK1/MAPK3",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/40","42/2914",0.112233754435678,0.231545313205138,0.158053224596474,"PPP2R5C/PLK1",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/40","42/2914",0.112233754435678,0.231545313205138,0.158053224596474,"MAPK1/MAPK3",2
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/40","44/2914",0.121255169658377,0.248049741383948,0.169319175341376,"ESR1/YAP1",2
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","3/40","89/2914",0.121316904082979,0.248049741383948,0.169319175341376,"MAPK1/MAPK3/STAT3",3
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/40","45/2914",0.12583290697921,0.251138952329032,0.171427875986492,"STAT3/STAT1",2
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"MAPK3",1
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"E2F1",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"PRKCD",1
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"BRCA1",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"E2F1",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"GSK3A",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"KPNA2",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"EP300",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"TP53",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/40","10/2914",0.129279807480728,0.251138952329032,0.171427875986492,"CSNK2A1",1
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/40","46/2914",0.130452673495795,0.251138952329032,0.171427875986492,"MAPK1/MAPK3",2
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","2/40","46/2914",0.130452673495795,0.251138952329032,0.171427875986492,"BRCA1/TP53",2
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","3/40","92/2914",0.130504521079279,0.251138952329032,0.171427875986492,"CTNNB1/ROCK2/PRKCD",3
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/40","47/2914",0.135112530966189,0.255743576843934,0.174571000511718,"PPP2R5C/PLK1",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","5/40","202/2914",0.139781256707912,0.255743576843934,0.174571000511718,"FOXO1/MAPK1/PPP2R5C/MAPK3/DUSP2",5
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"E2F1",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"E2F1",1
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"FOXO1",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"EP300",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"EP300",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"TP53",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"CEBPB",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"ROCK2",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"ROCK2",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"TP53",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"ESR1",1
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","1/40","11/2914",0.14127319856226,0.255743576843934,0.174571000511718,"FOXO1",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/40","49/2914",0.144544979244421,0.259614119584098,0.177213039569012,"STAT3/STAT1",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/40","49/2914",0.144544979244421,0.259614119584098,0.177213039569012,"MAPK1/MAPK3",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","3/40","97/2914",0.146355311988817,0.261425702938975,0.178449629448117,"FOXO1/ESR1/GSK3A",3
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/40","50/2914",0.14931390473803,0.261425702938975,0.178449629448117,"MAPK1/MAPK3",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"KPNA2",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"CSNK2A1",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"YAP1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"NOTCH1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"GSK3A",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/40","12/2914",0.15310546589175,0.261425702938975,0.178449629448117,"CTNNB1",1
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/40","51/2914",0.154115589068828,0.261425702938975,0.178449629448117,"EP300/NOTCH1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/40","51/2914",0.154115589068828,0.261425702938975,0.178449629448117,"EP300/NOTCH1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/40","51/2914",0.154115589068828,0.261425702938975,0.178449629448117,"EP300/NOTCH1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/40","51/2914",0.154115589068828,0.261425702938975,0.178449629448117,"EP300/NOTCH1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/40","51/2914",0.154115589068828,0.261425702938975,0.178449629448117,"EP300/NOTCH1",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/40","52/2914",0.158948300699703,0.267640888678176,0.182692125804225,"MAPK1/MAPK3",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/40","52/2914",0.158948300699703,0.267640888678176,0.182692125804225,"MAPK1/MAPK3",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","8/40","393/2914",0.161731703466114,0.270496965717676,0.184641688848885,"EP300/ESR1/BRCA1/SMAD3/PIAS1/PEX14/SMAD4/TP53",8
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/40","53/2914",0.163810347243123,0.270496965717676,0.184641688848885,"PRKAA1/CSNK2A1",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/40","13/2914",0.164778719290899,0.270496965717676,0.184641688848885,"EP300",1
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","1/40","13/2914",0.164778719290899,0.270496965717676,0.184641688848885,"GSK3A",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/40","13/2914",0.164778719290899,0.270496965717676,0.184641688848885,"NOTCH1",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/40","13/2914",0.164778719290899,0.270496965717676,0.184641688848885,"CTNNB1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/40","13/2914",0.164778719290899,0.270496965717676,0.184641688848885,"BRCA1",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/40","55/2914",0.173615867055189,0.280358087103822,0.191372907078453,"MAPK1/MAPK3",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/40","55/2914",0.173615867055189,0.280358087103822,0.191372907078453,"EP300/PIAS1",2
"R-HSA-168276","R-HSA-168276","NS1 Mediated Effects on Host Pathways","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"KPNA2",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"CEBPB",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"CTNNB1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"BRCA1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"E2F1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/40","14/2914",0.176295041672272,0.280358087103822,0.191372907078453,"EP300",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/40","56/2914",0.178556145020394,0.282971330170729,0.193156711240419,"PPP2R5C/PLK1",2
"R-HSA-168253","R-HSA-168253","Host Interactions with Influenza Factors","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"KPNA2",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"PLK1",1
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"YAP1",1
"R-HSA-3214842","R-HSA-3214842","HDMs demethylate histones","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"KDM6A",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"ROCK2",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"PPP2R5C",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"EP300",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"BRCA1",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"TP53",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/40","15/2914",0.187656489373344,0.285537116720903,0.194908121503351,"CTNNB1",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","2/40","59/2914",0.193508643845097,0.29346675126177,0.20032090352734,"ABL1/BRCA1",2
"R-HSA-450294","R-HSA-450294","MAP kinase activation","2/40","60/2914",0.198531791527956,0.296678216152513,0.202513054923688,"MAPK1/MAPK3",2
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/40","60/2914",0.198531791527956,0.296678216152513,0.202513054923688,"PPP2R5C/PLK1",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","2/40","60/2914",0.198531791527956,0.296678216152513,0.202513054923688,"E2F6/E2F1",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/40","16/2914",0.19886509248651,0.296678216152513,0.202513054923688,"CSNK2A1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/40","16/2914",0.19886509248651,0.296678216152513,0.202513054923688,"EP300",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/40","61/2914",0.203572062289753,0.301734642487724,0.205964580139863,"PPP2R5C/PLK1",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/40","61/2914",0.203572062289753,0.301734642487724,0.205964580139863,"PRKAA1/CSNK2A1",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","4/40","171/2914",0.20509334561154,0.303008878355113,0.20683437571011,"MAPK1/PPP2R5C/MAPK3/DUSP2",4
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","2/40","62/2914",0.208628085737947,0.307171462219743,0.209675762535656,"BRCA1/TP53",2
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/40","17/2914",0.209922855185108,0.307171462219743,0.209675762535656,"PRKCD",1
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","1/40","17/2914",0.209922855185108,0.307171462219743,0.209675762535656,"PIAS1",1
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","2/40","63/2914",0.213698524078367,0.310710869929817,0.212091768258229,"SMAD3/SMAD4",2
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","2/40","63/2914",0.213698524078367,0.310710869929817,0.212091768258229,"ABL1/BRCA1",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/40","64/2914",0.218782071516453,0.31609523266415,0.215767143418186,"EP300/NOTCH1",2
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","2/40","64/2914",0.218782071516453,0.31609523266415,0.215767143418186,"MAPK1/MAPK3",2
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","1/40","18/2914",0.220831756045515,0.318053283864295,0.217103712497577,"PLK1",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/40","177/2914",0.222650784346893,0.319667897275476,0.218205850358116,"MAPK1/PPP2R5C/MAPK3/DUSP2",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"E2F1",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"PLK1",1
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"EP300",1
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"PPP2R5C",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"CTNNB1",1
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"PRKCD",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"EP300",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"CSNK2A1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"EP300",1
"R-HSA-9609507","R-HSA-9609507","Protein localization","1/40","19/2914",0.231593748365328,0.322401023560244,0.220071487008486,"PEX14",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/40","20/2914",0.242210760477724,0.333130715612005,0.227395593051633,"MAPK1",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/40","20/2914",0.242210760477724,0.333130715612005,0.227395593051633,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/40","20/2914",0.242210760477724,0.333130715612005,0.227395593051633,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/40","20/2914",0.242210760477724,0.333130715612005,0.227395593051633,"EP300",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","3/40","125/2914",0.24463594875361,0.335458875835788,0.228984799180025,"MAPK1/PTPRB/PRKCD",3
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/40","21/2914",0.252684696061999,0.344433305941653,0.235110760433627,"NOTCH1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/40","21/2914",0.252684696061999,0.344433305941653,0.235110760433627,"ROCK2",1
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","4/40","188/2914",0.255866473775418,0.347735445071637,0.237364806219894,"MAPK1/PPP2R5C/MAPK3/DUSP2",4
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","2/40","72/2914",0.259775785166354,0.348156025948738,0.237651895441911,"EP300/PRKCD",2
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"PRKCD",1
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"BRCA1",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"SMAD3",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"TP53",1
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"PEX14",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/40","22/2914",0.263017434450357,0.348156025948738,0.237651895441911,"EP300",1
"R-HSA-422475","R-HSA-422475","Axon guidance","5/40","254/2914",0.266553865944304,0.351820376376055,0.240153187275772,"MAPK1/ABL1/MAPK3/ROCK2/CSNK2A1",5
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/40","23/2914",0.273210830930988,0.356497323550976,0.24334567937173,"SMAD4",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/40","23/2914",0.273210830930988,0.356497323550976,0.24334567937173,"PIAS1",1
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","1/40","23/2914",0.273210830930988,0.356497323550976,0.24334567937173,"BRCA1",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/40","23/2914",0.273210830930988,0.356497323550976,0.24334567937173,"E2F1",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/40","24/2914",0.283266717047474,0.363406600581913,0.248061963624059,"EP300",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/40","24/2914",0.283266717047474,0.363406600581913,0.248061963624059,"BRCA1",1
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","1/40","24/2914",0.283266717047474,0.363406600581913,0.248061963624059,"TP53",1
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","1/40","24/2914",0.283266717047474,0.363406600581913,0.248061963624059,"BRCA1",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/40","24/2914",0.283266717047474,0.363406600581913,0.248061963624059,"TP53",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/40","24/2914",0.283266717047474,0.363406600581913,0.248061963624059,"STAT1",1
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","2/40","78/2914",0.290668229704056,0.368900001675033,0.251811768553171,"MAPK1/MAPK3",2
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","2/40","78/2914",0.290668229704056,0.368900001675033,0.251811768553171,"MAPK1/MAPK3",2
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","2/40","78/2914",0.290668229704056,0.368900001675033,0.251811768553171,"MAPK1/MAPK3",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/40","25/2914",0.293186900894568,0.368900001675033,0.251811768553171,"PLK1",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/40","25/2914",0.293186900894568,0.368900001675033,0.251811768553171,"PLK1",1
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","1/40","25/2914",0.293186900894568,0.368900001675033,0.251811768553171,"CTNNB1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/40","25/2914",0.293186900894568,0.368900001675033,0.251811768553171,"CSNK2A1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/40","26/2914",0.302973167410393,0.378097304288719,0.258089862959663,"NOTCH1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/40","26/2914",0.302973167410393,0.378097304288719,0.258089862959663,"PLK1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/40","26/2914",0.302973167410393,0.378097304288719,0.258089862959663,"PLK1",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/40","82/2914",0.311215665589455,0.383869419915855,0.262029918903721,"SMAD3/STAT3",2
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/40","27/2914",0.312627278665096,0.383869419915855,0.262029918903721,"NOTCH1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/40","27/2914",0.312627278665096,0.383869419915855,0.262029918903721,"PLK1",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/40","27/2914",0.312627278665096,0.383869419915855,0.262029918903721,"PLK1",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/40","27/2914",0.312627278665096,0.383869419915855,0.262029918903721,"BRCA1",1
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","1/40","27/2914",0.312627278665096,0.383869419915855,0.262029918903721,"PEX14",1
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","2/40","83/2914",0.316338675330275,0.387388003479321,0.264431710028403,"MAPK1/MAPK3",2
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","2/40","84/2914",0.321454556967838,0.388276700418085,0.265038336070262,"MAPK1/MAPK3",2
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","2/40","84/2914",0.321454556967838,0.388276700418085,0.265038336070262,"MAPK1/MAPK3",2
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/40","28/2914",0.322150974146009,0.388276700418085,0.265038336070262,"PLK1",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/40","28/2914",0.322150974146009,0.388276700418085,0.265038336070262,"PLK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/40","28/2914",0.322150974146009,0.388276700418085,0.265038336070262,"EP300",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/40","28/2914",0.322150974146009,0.388276700418085,0.265038336070262,"EP300",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/40","29/2914",0.331545971039342,0.392509470004592,0.267927631788931,"EP300",1
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","1/40","29/2914",0.331545971039342,0.392509470004592,0.267927631788931,"PRKCD",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/40","29/2914",0.331545971039342,0.392509470004592,0.267927631788931,"PPP2R5C",1
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","2/40","86/2914",0.331661932078116,0.392509470004592,0.267927631788931,"MAPK1/MAPK3",2
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","2/40","86/2914",0.331661932078116,0.392509470004592,0.267927631788931,"MAPK1/MAPK3",2
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","2/40","86/2914",0.331661932078116,0.392509470004592,0.267927631788931,"MAPK1/MAPK3",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","2/40","86/2914",0.331661932078116,0.392509470004592,0.267927631788931,"SMAD3/SMAD4",2
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","2/40","87/2914",0.336751975795723,0.39417372662848,0.269063656190895,"MAPK1/MAPK3",2
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","2/40","87/2914",0.336751975795723,0.39417372662848,0.269063656190895,"MAPK1/MAPK3",2
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","2/40","87/2914",0.336751975795723,0.39417372662848,0.269063656190895,"MAPK1/MAPK3",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/40","87/2914",0.336751975795723,0.39417372662848,0.269063656190895,"MAPK1/MAPK3",2
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/40","30/2914",0.340813964508468,0.39417372662848,0.269063656190895,"CSNK2A1",1
"R-HSA-168254","R-HSA-168254","Influenza Infection","1/40","30/2914",0.340813964508468,0.39417372662848,0.269063656190895,"KPNA2",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/40","30/2914",0.340813964508468,0.39417372662848,0.269063656190895,"PLK1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/40","30/2914",0.340813964508468,0.39417372662848,0.269063656190895,"TP53",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/40","30/2914",0.340813964508468,0.39417372662848,0.269063656190895,"PIAS1",1
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","1/40","31/2914",0.349956627968822,0.401988379169519,0.274397951306245,"CTNNB1",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/40","31/2914",0.349956627968822,0.401988379169519,0.274397951306245,"PRKCD",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/40","153/2914",0.35118944024158,0.401988379169519,0.274397951306245,"MAPK1/MAPK3/PRKCD",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","2/40","90/2914",0.351959257744491,0.401988379169519,0.274397951306245,"MAPK1/MAPK3",2
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","2/40","90/2914",0.351959257744491,0.401988379169519,0.274397951306245,"MAPK1/MAPK3",2
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/40","32/2914",0.358975613359473,0.408982166464275,0.279171922408388,"EP300",1
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","1/40","33/2914",0.367872551411389,0.417043635015881,0.284674694552325,"BRCA1",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/40","33/2914",0.367872551411389,0.417043635015881,0.284674694552325,"EP300",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","7/40","428/2914",0.371311438023216,0.419902811394156,0.286626373210904,"CTNNB1/EP300/MAPK1/ABL1/MAPK3/PTPRB/PRKCD",7
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/40","34/2914",0.376649051912445,0.421773265955746,0.287903148675837,"PLK1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/40","34/2914",0.376649051912445,0.421773265955746,0.287903148675837,"EP300",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/40","34/2914",0.376649051912445,0.421773265955746,0.287903148675837,"ROCK2",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/40","34/2914",0.376649051912445,0.421773265955746,0.287903148675837,"FOXO1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/40","35/2914",0.385306703969217,0.430415781507077,0.293802544490006,"CTNNB1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/40","165/2914",0.397051805488502,0.442456756481104,0.302021734486067,"MAPK1/MAPK3/PRKCD",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/40","37/2914",0.402271717318179,0.446102776105874,0.304510513682934,"EP300",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/40","37/2914",0.402271717318179,0.446102776105874,0.304510513682934,"PLK1",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/40","38/2914",0.41058215572877,0.454218906579171,0.310050598147584,"ROCK2",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/40","39/2914",0.418779900433517,0.461060563458054,0.314720724769115,"EP300",1
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","1/40","39/2914",0.418779900433517,0.461060563458054,0.314720724769115,"E2F1",1
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/40","40/2914",0.426866440949224,0.465487690368439,0.317742689127618,"PLK1",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/40","40/2914",0.426866440949224,0.465487690368439,0.317742689127618,"CTNNB1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/40","40/2914",0.426866440949224,0.465487690368439,0.317742689127618,"PLK1",1
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","1/40","40/2914",0.426866440949224,0.465487690368439,0.317742689127618,"E2F1",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/40","42/2914",0.442711771840522,0.478212244110753,0.326428491153513,"PPP2R5C",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/40","42/2914",0.442711771840522,0.478212244110753,0.326428491153513,"PLK1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/40","42/2914",0.442711771840522,0.478212244110753,0.326428491153513,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/40","42/2914",0.442711771840522,0.478212244110753,0.326428491153513,"STAT1",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","2/40","109/2914",0.445161007384416,0.478600331882776,0.32669340052674,"EP300/KDM6A",2
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","2/40","109/2914",0.445161007384416,0.478600331882776,0.32669340052674,"EP300/KDM6A",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","2/40","110/2914",0.449880979003215,0.482542127361763,0.329384076824738,"MAPK1/MAPK3",2
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","1/40","44/2914",0.458129685319727,0.490241579150548,0.334639735710671,"PRKCD",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/40","46/2914",0.473131422857058,0.505114665894015,0.344792130017289,"PIAS1",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/40","47/2914",0.480479659637294,0.50939741693028,0.347715543158568,"EP300",1
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","1/40","47/2914",0.480479659637294,0.50939741693028,0.347715543158568,"STAT3",1
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","1/40","47/2914",0.480479659637294,0.50939741693028,0.347715543158568,"STAT3",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/40","48/2914",0.487727937842564,0.514699068045839,0.351334459226877,"EP300",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/40","48/2914",0.487727937842564,0.514699068045839,0.351334459226877,"BRCA1",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","2/40","119/2914",0.491369301530543,0.517349747358594,0.353143817433929,"EP300/CSNK2A1",2
"R-HSA-69306","R-HSA-69306","DNA Replication","1/40","51/2914",0.508886189048185,0.534563932532268,0.364894249510649,"E2F1",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","1/40","52/2914",0.515747716270704,0.540531931469067,0.368968015735033,"EP300",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/40","126/2914",0.52232439670895,0.543891386613537,0.37126118553027,"CTNNB1/KPNA2",2
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","1/40","53/2914",0.522515742598158,0.543891386613537,0.37126118553027,"PPP2R5C",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","1/40","53/2914",0.522515742598158,0.543891386613537,0.37126118553027,"PRKCD",1
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","2/40","127/2914",0.526648078571615,0.546949705183219,0.373348798987396,"MAPK1/MAPK3",2
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/40","55/2914",0.535776244042955,0.55517085921193,0.378960572709592,"STK11",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/40","57/2914",0.54867743688061,0.567255679664378,0.387209691703793,"CTNNB1",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/40","61/2914",0.573439623769198,0.591521053347506,0.403773277049435,"ROCK2",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/40","62/2914",0.579420140786103,0.59634702130345,0.407067490983969,"STAT3",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","3/40","217/2914",0.582056387748626,0.597717097732894,0.408002707484876,"MAPK1/PRKCD/KPNA2",3
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/40","64/2914",0.591136921063629,0.60568391464685,0.413440870259974,"ABL1",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/40","66/2914",0.602535225984165,0.615984672992741,0.42047218542598,"EP300",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/40","68/2914",0.613623495999614,0.625923298814751,0.427256308315286,"ROCK2",1
"R-HSA-69242","R-HSA-69242","S Phase","1/40","71/2914",0.6296925140292,0.640887047611941,0.437470588693971,"E2F1",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/40","72/2914",0.634902608801916,0.644756973018354,0.440112206358196,"ESR1",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/40","76/2914",0.655037521589072,0.663732709928749,0.453065076646377,"CTNNB1",1
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","1/40","80/2914",0.674088264758178,0.681528532581116,0.465212535455278,"PLK1",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","5/40","436/2914",0.736343669944869,0.742831279371696,0.507057894675692,"MAPK1/MAPK3/ROCK2/PRKCD/KPNA2",5
"R-HSA-1430728","R-HSA-1430728","Metabolism","3/40","289/2914",0.774170341682565,0.779274761517835,0.531934277570207,"EP300/STK11/CSNK2A1",3
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/40","109/2914",0.784635889198049,0.788077274676987,0.537942888023593,"PRKCD",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","5/40","486/2914",0.821728773547256,0.82352686714364,0.562140840132524,"MAPK1/MAPK3/ROCK2/PRKCD/KPNA2",5
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","1/40","296/2914",0.986636093638134,0.986636093638134,0.67347947554706,"PPP2R5C",1
